# Chinese Liver Cancer Clinical Survey

> **NCT03161925** · — · UNKNOWN · sponsor: **Beijing Insight Science & Technology Co. Ltd.** · enrollment: 5000 (actual)

## Conditions studied

- Primary Liver Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03161925
- **Lead sponsor:** Beijing Insight Science & Technology Co. Ltd.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-11-28
- **Primary completion:** 2017-08-31
- **Final completion:** 2017-08-31
- **Target enrollment:** 5000 (ACTUAL)
- **Last updated:** 2017-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03161925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03161925, "Chinese Liver Cancer Clinical Survey". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03161925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*